World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
51716
World Ranking
1289
National Ranking
669

Medicine

D-Index
85
Citations
51788
World Ranking
14340
National Ranking
7249

Overview

Kathrin U. Jansen is affiliated with Pfizer in the United States and has a significant body of research in medicine, focusing extensively on epidemiology, infectious diseases, immunology, pulmonary and respiratory medicine, and public health. Their research contributions span multiple specialized subfields and main topics related to respiratory infections and vaccine development.

The scientist has contributed notably to the following main topics:

  • Respiratory viral infections research
  • Pneumonia and Respiratory Infections
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Clostridium difficile and Clostridium perfringens research
  • Influenza Virus Research Studies

Jansen has published in several frequent venues, including:

  • New England Journal of Medicine
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases

Among recent papers authored or coauthored by Jansen are:

  • "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates" (2020, New England Journal of Medicine)
  • "Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants" (2023, New England Journal of Medicine)
  • "BNT162b vaccines protect rhesus macaques from SARS-CoV-2" (2021, Nature)
  • "Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age" (2021, New England Journal of Medicine)
  • "Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults" (2023, New England Journal of Medicine)

Jansen frequently collaborates with fellow researchers, with numerous coauthored publications alongside:

  • William C. Gruber
  • Kena A. Swanson
  • Daniel A. Scott
  • Alejandra Gurtman
  • David Cooper

Best Publications

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Fernando P. Polack;Stephen J. Thomas;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses.

    Ugur Sahin;Alexander Muik;Evelyna Derhovanessian;Isabel Vogler

  • A controlled trial of a human papillomavirus type 16 vaccine.

    Laura A. Koutsky;Kevin A. Ault;Cosette M. Wheeler;Darron R. Brown

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

    Marc J.M. Bonten;Susanne M. Huijts;Marieke Bolkenbaas;Chris Webber

  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

    Robert W Frenck;Nicola P Klein;Nicholas Kitchin;Alejandra Gurtman

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.

    Stephen J. Thomas;Edson D. Moreira;Nicholas Kitchin;Judith Absalon

  • BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

    Ugur Sahin;Alexander Muik;Isabel Vogler;Evelyna Derhovanessian

  • Turning the corner on therapeutic cancer vaccines

    Robert E. Hollingsworth;Kathrin Jansen

  • Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.

    Constance Mao;Laura A. Koutsky;Kevin A. Ault;Cosette M. Wheeler

  • BNT162b vaccines protect rhesus macaques from SARS-CoV-2.

    Annette B. Vogel;Isis Kanevsky;Ye Che;Kena A. Swanson

  • CD21 is a ligand for CD23 and regulates IgE production.

    Jean-Pierre Aubry;Sibylle Pochon;Pierre Graber;Kathrin U. Jansen

  • Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa

  • The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes

    Joseph G. Joyce;Jwu-Sheng Tung;Craig T. Przysiecki;James C. Cook

  • Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

    Emmanuel B. Walter;Kawsar R. Talaat;Charu Sabharwal;Alejandra Gurtman

  • Neutralizing Activity of BNT162b2-Elicited Serum.

    Yang Liu;Jianying Liu;Hongjie Xia;Xianwen Zhang

  • A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

    Nelly A. Kuklin;Desmond J. Clark;Susan Secore;James Cook

  • SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

    Ann R Falsey;Robert W Frenck;Edward E Walsh;Nicholas Kitchin

Frequent Co-Authors

Annaliesa S. Anderson
Annaliesa S. Anderson Pfizer (United States)
William C. Gruber
William C. Gruber Pfizer (United States)
David A. Cooper
David A. Cooper University of New South Wales
Daniel A. Scott
Daniel A. Scott Pfizer (United States)
Philip R. Dormitzer
Philip R. Dormitzer Pfizer (United States)
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
Robert W. Frenck
Robert W. Frenck Cincinnati Children's Hospital Medical Center
Laura A. Koutsky
Laura A. Koutsky University of Washington
Ugur Sahin
Ugur Sahin Johannes Gutenberg University of Mainz
Ann R. Falsey
Ann R. Falsey University of Rochester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into nursing specialties like Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs can be a natural extension. Many students seek the what is the easiest np program to ensure a manageable balance between coursework and clinical training. This is particularly important for working professionals aiming to advance their careers efficiently.

Online PMHNP programs vary widely, but students often consider options with strong support systems, such as those highlighted in the top online pmhnp programs. These programs usually provide excellent clinical placement rates, a crucial factor for hands-on experience and licensure.

Cost is another key factor when selecting a program. For those mindful of tuition fees, reviewing the cheapest online pmhnp certificate programs can make advanced education more accessible. Affordable programs still maintain quality, enabling graduates to enter the workforce without overwhelming debt.

Career pathways following these degrees often lead to competitive salaries. Understanding compensation trends, such as the dnp salary by state, can help prospective students make informed decisions about where to train and ultimately practice.

Best Scientists Citing Kathrin U. Jansen

Trending Scientists

Recently Published Articles